What was the cause of the unusually high number of adverse events with heparin reported in North America in 2007?
An investigation into this problem conducted by the US Centers for Disease Control identified the cause of these reactions to be a contaminant in heparin manufactured in China. The contaminant was an oversulfated chondroitin sulfate.